コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 nt mice were more susceptible to LPS-induced endotoxic shock.
2 re susceptible to lipopolysaccharide-induced endotoxic shock.
3 ndering them more susceptible to LPS-induced endotoxic shock.
4 cytokine production within the heart during endotoxic shock.
5 nst V. vulnificus lipopolysaccharide-induced endotoxic shock.
6 ally dimorphic response to Vibrio vulnificus endotoxic shock.
7 ar tone and increases in oxidative stress is endotoxic shock.
8 educed the lethality associated with ensuing endotoxic shock.
9 could protect endotoxin-sensitive mice from endotoxic shock.
10 gulating TNF-alpha secretion and attenuating endotoxic shock.
11 ute to the beneficial effect of TGF-beta1 on endotoxic shock.
12 onsible for the overall host response during endotoxic shock.
13 an enhanced susceptibility to pathogens and endotoxic shock.
14 contributes to the hemodynamic compromise of endotoxic shock.
15 tes to the reduction in vascular tone during endotoxic shock.
16 ing protection in this experimental model of endotoxic shock.
17 y relevant model of gram-negative sepsis and endotoxic shock.
18 o block the organ damage or lethal effect of endotoxic shock.
19 umption (VO2) in the presence and absence of endotoxic shock.
20 be involved in the hemodynamic compromise of endotoxic shock.
21 nt for the acidotic mucosal tonometric pH in endotoxic shock.
22 rats and improved survival in lethal murine endotoxic shock.
23 vels of PAF are observed in animal models of endotoxic shock.
24 ascular energetic and contractile failure in endotoxic shock.
25 ng in the microcirculation during septic and endotoxic shock.
26 ory genes and show resistance to LPS-induced endotoxic shock.
27 nnate immunity, macrophages, and LPS-induced endotoxic shock.
28 of light and myeloid clocks on mortality by endotoxic shock.
29 y to influenza A virus (IAV) and LPS-induced endotoxic shock.
30 ssociated with hemorrhagic, cardiogenic, and endotoxic shock.
31 cterial lipopolysaccharide (LPS), a model of endotoxic shock.
32 ver a key role for this lncRNA in modulating endotoxic shock.
33 by the fall in oxygen delivery (DO2) during endotoxic shock.
34 ation and promoted the recovery of mice from endotoxic shock.
35 macrophages were sufficient to induce lethal endotoxic shock.
36 nd is protective in an experimental model of endotoxic shock.
37 phrine at 18 hours after induction of murine endotoxic shock.
38 uch higher levels of IL-17A and IL-23 during endotoxic shock.
39 oving survival in an in vivo murine model of endotoxic shock.
40 leads to greater sensitivity to LPS-induced endotoxic shock.
41 cytokines, but only partial protection from endotoxic shock.
42 o partial recovery of CCL5 production during endotoxic shock.
43 ent of AC7 are hypersensitive to LPS-induced endotoxic shock.
44 d showed reduced CCL5 levels in serum during endotoxic shock.
45 cking caspase 1 are resistant to LPS-induced endotoxic shock.
46 ible to LPS-induced splenocyte apoptosis and endotoxic shock.
47 agocytosis of bacteria and susceptibility to endotoxic shock.
48 m-derived molecules, are more susceptible to endotoxic shock.
49 immune response to an infectious disease or endotoxic shock.
50 oration of alpha1-adrenoceptor expression in endotoxic shock.
51 ATF3-deficient mice are more susceptible to endotoxic shock.
52 ord complete protection in a murine model of endotoxic shock.
53 l mice are hypersensitive to the LPS-induced endotoxic shock.
54 mal antiinflammatory response to LPS-induced endotoxic shock.
55 echolamine-producing adrenal glands prior to endotoxic shock.
56 e are markedly hypersensitive to LPS-induced endotoxic shock.
57 back element for cardiovascular tolerance in endotoxic shock.
58 ve immune response to LPS and development of endotoxic shock.
59 e cardiovascular dysfunction associated with endotoxic shock.
60 n macrophages, a major cell type involved in endotoxic shock.
61 ta protect AUF1 knockout mice against lethal endotoxic shock.
62 cytokines that facilitate the development of endotoxic shock.
63 production, and increased susceptibility to endotoxic shock.
64 sive ODN might be of use in the treatment of endotoxic shock.
65 e life-threatening multiple-organ failure of endotoxic shock.
66 uppressive ODN protect mice from LPS-induced endotoxic shock.
67 tic shock, were intravenously infused during endotoxic shock.
68 ng a murine model of D-galactosamine-induced endotoxic shock.
69 ted in a model of lipopolysaccharide-induced endotoxic shock.
70 ful in treating organ injury associated with endotoxic shock.
71 hages, and this function protected mice from endotoxic shock.
72 st from cytokine-induced immunopathology and endotoxic shock.
73 ity reaction and increased susceptibility to endotoxic shock.
74 were resistant to lipopolysaccharide-induced endotoxic shock.
75 ection from lipopolysaccharide (LPS)-induced endotoxic shock.
76 t hypotension that develops in Gram-negative endotoxic shock.
77 and is also essential in protection against endotoxic shock.
78 sistant to the lethal effects of LPS-induced endotoxic shock.
79 mulation by microbial components may lead to endotoxic shock.
80 Upon LPS challenge, merkd animals died of endotoxic shock (15/17, 88.2%), whereas control wild-typ
81 gy reminiscent of lipopolysaccharide-induced endotoxic shock, a type of systemic inflammatory respons
82 e conditions, norepinephrine infusion during endotoxic shock actually increases renal blood flow and
83 owever, these mice are highly susceptible to endotoxic shock and appear to be compromised in their ab
84 umatic brain injury, diabetes, Parkinsonism, endotoxic shock and arthritis, implicating PARP in the p
85 orming CM-LPS complexes, and protect against endotoxic shock and death in rodent models of gram-negat
86 ve in controlling clinical manifestations of endotoxic shock and death under conditions wherein fluni
87 e found increased production of IL-12 during endotoxic shock and enhanced Th1 cells in TTP knockout m
88 AP12-deficient mice were more susceptible to endotoxic shock and had enhanced resistance to infection
89 icient mice exhibit diminished recovery from endotoxic shock and hyperresponsiveness of a subset of e
90 out (SR-A(-/-)) mice are more susceptible to endotoxic shock and Listeria monocytogenes infection in
91 vents regulating the p28 subunit of IL-27 in endotoxic shock and polymicrobial sepsis following cecal
92 ransfer experiments showed that responses to endotoxic shock and polymicrobial sepsis were transferab
96 hypersensitive to lipopolysaccharide-induced endotoxic shock and showed prolonged inflammation in a m
97 cated in serious autoimmune diseases such as endotoxic shock and thus are important therapeutic targe
98 tion may be protective in some patients with endotoxic shock and with diseases characterized by chron
99 how that c-peptide has beneficial effects in endotoxic shock, and this therapeutic effect is associat
100 onclusion, hypometabolism and hypothermia in endotoxic shock are not consequential to hypoxia but ser
101 pendent cytokine responses and the resultant endotoxic shock are not coupled to SRA-mediated clearanc
104 fective in that they are highly resistant to endotoxic shock as compared with normal responder mice.
105 nces susceptibility and worsens outcome from endotoxic shock by augmenting sympathetic activity, part
106 cterial and lipopolysaccharide (LPS)-induced endotoxic shock by blocking the non-canonical inflammaso
107 experiments in a mouse model of LPS-induced endotoxic shock confirmed the proinflammatory potential
108 ve apoptosis of leukocytes during sepsis and endotoxic shock constitutes an important mechanism linke
109 ammation using three models of inflammation: endotoxic shock, diabetes, and contact hypersensitivity.
110 liest drops in cardiac output and DO2 during endotoxic shock did not precede the reduction in VO2 tha
111 action of exogenous low-dose vasopressin in endotoxic shock does not impair blood flow to any of the
112 trite and rings taken from rats subjected to endotoxic shock exhibited reduced endothelium-dependent
116 ve cells play an important role in mediating endotoxic shock; (ii) tamLITAF(i)-/- mice show a similar
117 function in the first 4 h after induction of endotoxic shock in anesthetized canine preparations (n =
123 eficient in MKP-1 were highly susceptible to endotoxic shock in vivo, associated with enhanced produc
125 ion of the cytokines IL-17A and IL-23 during endotoxic shock in young adult male C57BL/6J mice and ha
126 UF1 knockout mice display symptoms of severe endotoxic shock, including vascular hemorrhage, intravas
127 ut of Mkp-1 substantially sensitizes mice to endotoxic shock induced by lipopolysaccharide (LPS) chal
129 lling diseases such as rheumatoid arthritis, endotoxic shock, inflammatory bowel disease, osteoporosi
135 aken to determine if V antigen could prevent endotoxic shock, known to be mediated by excessive produ
137 the antiinflammatory response to LPS-induced endotoxic shock, likely through its essential role in fa
140 creased survival rates of mutants faced with endotoxic shock may indicate a contribution of grancalci
144 ole in various inflammatory diseases such as endotoxic shock, multiple sclerosis, cerebral malaria, a
145 Foremost, both models result in DIC and endotoxic shock, neither of which is likely to respond t
148 that U90926 expression is protective during endotoxic shock, potentially mediated by the paracrine a
152 The present studies provide evidence that endotoxic shock results from disseminated endothelial ap
155 X) was not sufficient to reverse LPS-induced endotoxic shock susceptibility or restore IL-10 release.
159 edema, leukocyte infiltration, and signs of endotoxic shock that correlated with higher levels of TN
160 we have developed a model for V. vulnificus endotoxic shock that mimics the sexually dimorphic respo
161 ry cytokines and exhibit hypersensitivity to endotoxic shock; these effects are mitigated when the an
162 -33 protects animals from lipopolysaccharide endotoxic shock through attenuated neutrophil extravasat
164 iologic protective factor against the lethal endotoxic shock triggered by an acute inflammatory respo
171 y responses and it blocks the hypotension of endotoxic shock, we determined whether TGF-beta1 could b
172 2cre)) resulted in resistance to LPS-induced endotoxic shock, whereas Socs2(-/-) mice were highly sus
173 in the potentially lethal condition known as endotoxic shock, whereby uncontrolled inflammation can l
174 in IL-1beta showed unaltered sensitivity to endotoxic shock, with or without pretreatment with D-gal
175 e induced by SIVsmmPBj4 clinically resembles endotoxic shock, with the development of severe gastroin